Expertise in
127
conditions

Dr. Morey A. Blinder

Internal Medicine
Office
4921 Parkview Pl Ste 7B, 
Saint Louis, MO 
Accepting New Patients
Offers Telehealth
Expertise in
127
conditions
Office
4921 Parkview Pl Ste 7B, 
Saint Louis, MO 

Overview

Morey Blinder is a primary care provider, practicing in Internal Medicine in Saint Louis, Missouri.

Dr. Blinder is highly rated in 127 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobin SC Disease, Anaplastic Large Cell Lymphoma, Acute Myeloblastic Leukemia with Maturation, and Thrombectomy.

He is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 5 clinical trials. Dr. Blinder is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Pathology in MO

Hospital Affiliations

Barnes-Jewish St Peters Hospital
Barnes Jewish Hospital
Christian Hospital Northeast
Memorial Hospital
Missouri Baptist Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Celtic
  • HMO
  • INSURANCE PLAN
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Sutter Health
  • HMO
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Office
4921 Parkview Pl Ste 7B, Saint Louis, MO 63110
Other Locations
Washington University Cancer Center Pharmacy-North County
1255 Graham Rd, Florissant, MO 63031

Additional Areas of Focus

Dr. Blinder has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial
Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy - The C-TRACT Trial
Enrollment Status: Active_not_recruiting
Publish Date: January 28, 2026
Intervention Type: Device
Study Phase: Not Applicable
Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia
Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia
Enrollment Status: Terminated
Publish Date: December 15, 2023
Intervention Type: Drug
Study Drugs: Fostamatinib, Ruxolitinib
Study Phase: Phase 2
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion
Enrollment Status: Completed
Publish Date: December 23, 2022
Intervention Type: Drug
Study Drug: Sutimlimab
Study Phase: Phase 3
A Pilot Study of Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
A Pilot Study of Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
Enrollment Status: Terminated
Publish Date: February 14, 2022
Intervention Type: Drug, Procedure, Radiation
Study Drugs: Alemtuzumab, Cyclophosphamide, Mycophenolate mofetil, Sirolimus, Fludarabine
Study Phase: Phase 1
Adjuvant Low Dose Rituximab for Acquired TTP With Severe ADAMTS13 Deficiency
Adjuvant Low Dose Rituximab for Acquired TTP With Severe ADAMTS13 Deficiency
Enrollment Status: Completed
Publish Date: August 17, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 4 Less Clinical Trials

16 Total Publications

Multidisciplinary Management and Staged Surgical Treatment for Chronic Thromboembolic Pulmonary Hypertension and Subclavian Vein Thrombosis Caused by Venous Thoracic Outlet Syndrome.
Multidisciplinary Management and Staged Surgical Treatment for Chronic Thromboembolic Pulmonary Hypertension and Subclavian Vein Thrombosis Caused by Venous Thoracic Outlet Syndrome.
Journal: Cureus
Published: May 27, 2025
Similar Doctors
Expertise in
28
conditions
Dr. Michael P. Whyte
Internal Medicine
Expertise in
28
conditions
Dr. Michael P. Whyte
Internal Medicine

Office

4921 Parkview Pl Ste 5C, 
Saint Louis, MO 
 (0.1 miles away)
314-454-7775
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Whyte is a primary care provider, practicing in Internal Medicine in Saint Louis, Missouri. Dr. Whyte is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Hypophosphatasia (HPP), Juvenile Paget's Disease, Rickets, Osteopetrosis, and Leg or Foot Amputation. Dr. Whyte is currently accepting new patients.

Expertise in
13
conditions
Dr. John C. Morris
Internal Medicine
Expertise in
13
conditions
Dr. John C. Morris
Internal Medicine

Office

4488 Forest Park Ave Ste 160, 
Saint Louis, MO 
 (0.9 miles away)
314-286-1967
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Morris is a primary care provider, practicing in Internal Medicine in Saint Louis, Missouri. Dr. Morris is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Primary Amyloidosis, Thyroidectomy, and Vertebroplasty. Dr. Morris is currently accepting new patients.

Expertise in
11
conditions
Dr. Daniel C. Link
Internal Medicine
Expertise in
11
conditions
Dr. Daniel C. Link
Internal Medicine

Barnes-Jewish Hospital

1 Barnes Jewish Hospital Plz, 
Saint Louis, MO 
 (0.1 miles away)
314-454-8304
Languages Spoken:
English

Daniel Link is a primary care provider, practicing in Internal Medicine in Saint Louis, Missouri. Dr. Link is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Agranulocytosis, Severe Congenital Neutropenia, Cyclic Neutropenia, and Chronic Familial Neutropenia.

Frequently Asked Questions about Dr. Morey A. Blinder

How do I make an appointment with Dr. Morey A. Blinder?

You can book an appointment with Dr. Morey A. Blinder by calling their office at 314-362-7216. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Morey A. Blinder a top-rated expert for Sickle Cell Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Morey A. Blinder is classified as an Distinguished expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Morey A. Blinder specialize in?

While Dr. Morey A. Blinder is a Internal Medicine, they have specific expertise in Sickle Cell Disease, Hemoglobin SC Disease, and Anaplastic Large Cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Morey A. Blinder participate in research or clinical trials?

Yes. Dr. Morey A. Blinder has published 16 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Dr. Morey A. Blinder's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Morey A. Blinder accept my insurance?

Dr. Morey A. Blinder accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-362-7216 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Blinder's expertise for a condition
ConditionClose
    View All 58 Distinguished Conditions
    View All 69 Advanced Conditions
    View All 111 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile